DEXLANSOPRAZOLE
Identification of Dexlansoprazole
| No description |
Google image searchProduct monograph
Active ingredient
dexlansoprazole, 30 MG
DIN: 02536390
Dosage form(s): CAPSULE (DELAYED RELEASE)
Route(s) of administration: NASOGASTRIC, ORAL
Schedule: Prescription
Company: ALTIUS HEALTHCARE INC
Date: 23-JAN-2024
ATC:
- A02 — DRUGS FOR ACID RELATED DISORDERS (ATC, ATC/DDD, )
- A02B — DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) (ATC, ATC/DDD)
- A02BC — Proton pump inhibitors (ATC, ATC/DDD)
- A02BC06 — DEXLANSOPRAZOLE (ATC/DDD)
Reference brand drug: Dexilant
